Pharmacodynamics Stocks List
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
WTAI | D | WisdomTree Artificial Intelligence and Innovation Fund | 0.67 | |
PSCH | D | PowerShares S&P SmallCap Health Care Portfolio | 0.33 | |
HELX | D | Franklin Genomic Advancements ETF | 0.28 | |
SSLY | B | Syntax Stratified SmallCap ETF | 0.24 | |
XSHQ | C | PowerShares S&P SmallCap Quality Portfolio | 0.15 |
Compare ETFs
- Pharmacodynamics
Pharmacodynamics (PD) is the study of the biochemical and physiologic effects of drugs (especially pharmaceutical drugs). The effects can include those manifested within animals (including humans), microorganisms, or combinations of organisms (for example, infection). Pharmacodynamics is the study of how a drug affects an organism, whereas pharmacokinetics is the study of how the organism affects the drug. Both together influence dosing, benefit, and adverse effects. Pharmacodynamics is sometimes abbreviated as PD and pharmacokinetics as PK, especially in combined reference (for example, when speaking of PK/PD models).
Pharmacodynamics places particular emphasis on dose–response relationships, that is, the relationships between drug concentration and effect. One dominant example is drug-receptor interactions as modeled by
L
+
R
↽
−
−
⇀
LR
{\displaystyle {\ce {L + R <=> LR}}}
where L, R, and LR represent ligand (drug), receptor, and ligand-receptor complex concentrations, respectively. This equation represents a simplified model of reaction dynamics that can be studied mathematically through tools such as free energy maps.
Popular Now
Recent Comments
- LillyMilly1 on LILM
- LillyMilly1 on LILM
- TraderMike on RYDE what a RIDE!!! Holy Crap!
- Crunching_The_Market on RYDE what a RIDE!!! Holy Crap!
- LillyMilly1 on LILM
From the Blog
Featured Articles